Audio podcasts > PodCast news direct

Email this page News by email Send a press-release

PodCast news direct

All the breaking news across the pharmaceutical manufacturing and outsourcing sectors.

TFS and Siemens hope to have process analysis down PAT

US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production.

First USP OK for rHAs a "significant advantage", says Novozymes

Two recombinant human albumins made by Novozymes' biopharma division have become the first to comply with the USP-NF's recently revised excipient monograph.

Novartis comments on $490m cell-culture vaccine contract

Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman Matt Stober about the new plant.

Interview with IPEC China chairman Nevin Cheng

Since its inauguration last year, IPEC China has been working to improve the quality of excipient manufacturing in the country. in-PharmaTechnologist spoke with organisation president Nevin Cheng about the steps the body has taken so far and what it will be doing in 2009, including its plans for a new SFDA approved Drug Master File (DMF) scheme.

Latest podcast

All the breaking news across the pharmaceutical manufacturing and outsourcing sectors.

First podcast from in-PharmaTechnologist.com

Welcome to in-pharma technologist’s podcast. In the next three minutes Gareth Macdonald will take you through the top industry headlines this week. Product authenticity dominated the news, with US regulators announcing increased penalties for those convicted of selling dangerous counterfeits. In Europe IPEC sets out its new third party assessment scheme.